Proteome Analysis of Bevacizumab Intervention in Experimental Central Retinal Vein Occlusion

Bevacizumab is a frequently used inhibitor of vascular endothelial growth factor (VEGF) in the management of macular edema in central retinal vein occlusion (CRVO). Studying retinal protein changes in bevacizumab intervention may provide insights into mechanisms of action. In nine Danish Landrace pi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cehofski, Lasse Jørgensen, Kruse, Anders, Mæng, Mads Odgaard, Kjaergaard, Benedict, Grauslund, Jakob, Honoré, Bent, Vorum, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672637/
https://www.ncbi.nlm.nih.gov/pubmed/38003895
http://dx.doi.org/10.3390/jpm13111580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672637/
https://www.ncbi.nlm.nih.gov/pubmed/38003895
http://dx.doi.org/10.3390/jpm13111580

Ejemplares similares